Pelthos Therapeutics Inc. · AMEX:PTHS
Ikarian Capital, LLC reported a 7.70% stake in Pelthos Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Ikarian Capital, LLC reported a 7.70% stake in Pelthos Therapeutics Inc., 256,598 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 7.70%
- Shares
- 256,598
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 7.70% | 256,598 |
| Neil Shahrestani | 7.70% | 256,598 |
Source
Related
- Pelthos Therapeutics Inc.
- Ikarian Capital, LLC
- Pelthos Therapeutics Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Nov 14, 2025
- Form 4 · Friedberg Ezra M · Oct 6, 2026
- Form 4 · Greenleaf Peter · Oct 6, 2026
- Form 4 · Pauls Matthew · Oct 6, 2026
- Form 4 · Friedberg Ezra M · Jul 7, 2026
- Form 4 · Pauls Matthew · Jul 7, 2026